Related Experiment Videos
Stentless aortic bioprostheses: compelling data from the Second International Symposium
S Westaby1, H A Huysmans, T E David
1Oxford Heart Centre, John Radcliffe Hospital, United Kingdom.
The Annals of Thoracic Surgery
|February 10, 1998
Summary
Stentless aortic xenografts offer significant hemodynamic advantages over stented valves, leading to improved patient outcomes and reduced left ventricular strain in elderly patients with aortic stenosis.
Area of Science:
- Cardiovascular Surgery
- Biomedical Engineering
- Prosthetic Valve Technology
Background:
- Stentless aortic xenografts represent an advancement in prosthetic heart valves.
- Their application has been concentrated in specialized centers.
- This report reviews findings from the Second International Symposium on Stentless Bioprostheses, focusing on FDA-approved Toronto SPV and Freestyle valves.
Purpose of the Study:
- To summarize key findings on stentless bioprostheses.
- To evaluate the performance of the Toronto SPV and Freestyle valves.
- To assess the clinical utility of stentless aortic xenografts.
Main Methods:
- Stentless xenografts are primarily implanted in elderly patients with aortic stenosis.
- Implantation involves more complex techniques, resulting in longer surgical times.
- Serial echocardiographic assessments and clinical follow-up were conducted.
Main Results:
- Hemodynamic performance mimics aortic homografts, with improved orifice area and reduced pressure gradients over time.
- Left ventricular mass and thickness normalize within 6-12 months post-surgery.
- Improved hemodynamics correlate with better symptomatic status, low complication rates, and potentially enhanced bioprosthetic durability compared to stented valves.
Conclusions:
- Stentless xenografts provide substantial hemodynamic benefits.
- Careful instruction in reproducible implant techniques is essential.
- These valves are particularly well-suited for elderly patients with aortic stenosis.